Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.64 AUD | +4.44% | +4.49% | -13.34% |
28/05 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
27/05 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.34% | 1.83B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Larry Glass to Retire from the Neuren Pharmaceuticals Limited's Board of Directors on 31 December 2018